Treg Cell Therapy for Autoimmune Diseases from United States
Treg cell therapy involves regulatory T-cells expanded ex vivo from patient blood and modified for enhanced suppressive function to treat graft-versus-host disease. These cell cultures are classified as cell therapy products under tariff item 3002.51.00.
Duty Rate — United States → Canada
0%
Import Tips
• Obtain a Health Canada letter of authorization for the product before importation, as it is a biologic drug
• Keep detailed records of the cell expansion and modification steps for CBSA review
• Work with a customs broker to ensure proper classification and compliance with Canadian regulations